Sagent Pharmaceuticals IPO Research Information

Sagent Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Sagent Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Sagent Pharmaceuticals	SGNT -	Last trade $23.64	$16.00	$18.25	4.4 million	9/11/2013
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Jefferies
Co-Manager(s):
Industry: Health Care
Filing(s):

Sagent Pharmaceuticals Quote & Chart - Click for current quote - SGNT

About Sagent Pharmaceuticals (adapted from Sagent Pharmaceuticals prospectus):
They are an injectable pharmaceutical company with 21 marketed and 45 pipeline products.

This description is adapted from Sagent prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Sagent "SGNT" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.